Drug:
Reaction: DRUG INEFFECTIVE
20260101 - 20261231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 26556482 |
US |
1 | |
Drug ineffective, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, CRISABOROLE, PIMECROLIMUS, |
||||
| 202 | 26556491 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 203 | 26556495 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 204 | 26556496 |
US |
45 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 205 | 26556499 |
US |
45 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 206 | 26556500 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 207 | 26556501 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 208 | 26556502 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 209 | 26556522 |
US |
59 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 210 | 26556524 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 211 | 26556525 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 212 | 26556526 |
US |
55 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 213 | 26556528 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 214 | 26556530 |
US |
53 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 215 | 26556542 |
US |
||
CD4 lymphocytes decreased, Drug ineffective, Product size issue, |
||||
ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE, |
||||
| 216 | 26556549 |
EU |
45 | |
Breakthrough haemolysis, Drug ineffective, |
||||
PEGCETACOPLAN, PEGCETACOPLAN, |
||||
| 217 | 26556556 |
US |
49 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 218 | 26556557 |
US |
40 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 219 | 26556561 |
US |
31 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 220 | 26556562 |
US |
66 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 221 | 26556563 |
US |
37 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 222 | 26556565 |
US |
36 | |
Patient dissatisfaction with treatment, Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, ONABOTULINUMTOXINA, |
||||
| 223 | 26556566 |
US |
1 | |
Fatigue, Drug ineffective, |
||||
LINEZOLID, METOPROLOL TARTRATE, METOPROLOL, ROSUVASTATIN, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, FINASTERIDE, LOSARTAN, FUROSEMIDE, ERGOCALCIFEROL, EMPAGLIFLOZIN, ASCORBIC ACID, MELATONIN, |
||||
| 224 | 26556588 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 225 | 26556589 |
US |
35 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 226 | 26556590 |
US |
72 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 227 | 26556593 |
US |
33 | |
Drug ineffective, Off label use, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 228 | 26556597 |
US |
37 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 229 | 26556598 |
US |
36 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 230 | 26556609 |
|||
Drug ineffective, |
||||
VIGABATRIN, |
||||
| 231 | 26556610 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 232 | 26556612 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 233 | 26556613 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 234 | 26556614 |
US |
54 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 235 | 26556663 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 236 | 26556674 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 237 | 26556676 |
US |
43 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 238 | 26556679 |
US |
34 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 239 | 26556688 |
CA |
63 | 2 |
Alopecia, Application site reaction, Chronic spontaneous urticaria, Depression, Dyspnoea, Dyspnoea exertional, Haemorrhage, Headache, Hepatic enzyme increased, Urticaria, Tachycardia, Insomnia, Intervertebral disc protrusion, Malaise, Middle insomnia, Muscular weakness, Pain, Paraesthesia, Primary biliary cholangitis, Pruritus, Scratch, Skin burning sensation, Skin lesion, Skin plaque, Spinal meningeal cyst, Stress, Erythema, Product dose omission issue, Drug ineffective, Incorrect dose administered, Inappropriate schedule of product administration, Wrong technique in product usage process, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, NICOTINE, NICOTINE POLACRILEX, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, |
||||
| 240 | 26556745 |
US |
2 | |
Hypothyroidism, Dyslipidaemia, Drug ineffective, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, |
||||
| 241 | 26556766 |
|||
Drug ineffective, Off label use, |
||||
BIMEKIZUMAB, |
||||
| 242 | 26556797 |
US |
54 | 1 |
Drug ineffective, Weight increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 243 | 26556912 |
US |
2 | |
Drug ineffective, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, GUSELKUMAB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, CELECOXIB, CELECOXIB, CELECOXIB, |
||||
| 244 | 26556935 |
US |
38 | 2 |
Drug ineffective, |
||||
DUPILUMAB, |
||||
| 245 | 26556938 |
US |
||
Weight increased, Swelling face, Drug ineffective, |
||||
ORLISTAT, |
||||
| 246 | 26556960 |
US |
72 | 1 |
Hallucination, Delusion, Drug ineffective, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 247 | 26557005 |
KR |
44 | 1 |
Dizziness, Drug ineffective, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, ZOLPIDEM TARTRATE, |
||||
| 248 | 26557085 |
GB |
26 | 2 |
Disturbance in social behaviour, Adverse event, Weight decreased, Agitation, Anxiety, Product availability issue, Drug ineffective, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, CLOZAPINE, SERTRALINE, |
||||
| 249 | 26557139 |
AR |
65 | 2 |
Metastases to liver, Post procedural complication, Colon operation, Nasal discomfort, Feeling cold, Muscle spasms, Blister, Diarrhoea, Nausea, Dry skin, Nail disorder, Feeling hot, Pruritus, Gastrointestinal disorder, Vision blurred, Sneezing, Onychomadesis, Skin haemorrhage, Rhinitis, Skin laceration, Sensory loss, Retching, Limb injury, Impaired healing, Temperature intolerance, Loss of personal independence in daily activities, Pain in extremity, Nasal dryness, Cough, Epistaxis, Skin fissures, Rash, Localised infection, Acne, Erythema, Drug ineffective, Muscle spasms, |
||||
PANITUMUMAB, OXALIPLATIN, OXALIPLATIN, |
||||
| 250 | 26557148 |
|||
Drug ineffective, Off label use, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ADALIMUMAB, BUDESONIDE AND FORMOTEROL FUMARATE, FISH OIL, |
||||
| 251 | 26557161 |
US |
1 | |
Hallucination, Drug ineffective, Product distribution issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 252 | 26557185 |
US |
6 | 2 |
Dry skin, Haemorrhage, Scratch, Sleep disorder, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 253 | 26557200 |
US |
||
Drug ineffective, |
||||
ADAPALENE, ADAPLANE 0.1%, |
||||
| 254 | 26557233 |
US |
1 | |
Drug ineffective, |
||||
PEGCETACOPLAN, |
||||
| 255 | 26557235 |
TR |
40 | 1 |
Gastrointestinal disorder, Intentional overdose, Drug ineffective, Idiopathic generalised epilepsy, Status epilepticus, Suicide attempt, |
||||
RISPERIDONE, SERTRALINE, LITHIUM, LITHIUM BROMATUM, PROPRANOLOL HYDROCHLORIDE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, QUETIAPINE, QUETIAPINE, QUETIAPINE, QUETIAPINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, OLANZAPINE, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, PHENYTOIN, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
| 256 | 26557241 |
US |
64 | 2 |
Drug ineffective, |
||||
DUPILUMAB, |
||||
| 257 | 26557301 |
RS |
46 | 1 |
Drug ineffective, Product use in unapproved indication, |
||||
FLUOXETINE HYDROCHLORIDE, FLUOXETINE, CARBAMAZEPINE, OLANZAPINE, QUETIAPINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 258 | 26557323 |
US |
||
Drug ineffective, |
||||
RILZABRUTINIB, |
||||
| 259 | 26557324 |
US |
8 | 1 |
Drug ineffective, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 260 | 26557336 |
US |
66 | 1 |
Drug ineffective, |
||||
DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, GABAPENTIN, QUETIAPINE FUMARATE, QUETIAPINE, CELECOXIB, |
||||
| 261 | 26557338 |
US |
18 | 1 |
Drug ineffective, Off label use, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE, LITHIUM CARBONATE, LITHIUM CARBONATE, LITHIUM CARBONATE, RISPERIDONE, RISPERIDONE, RISPERIDONE, ZIPRASIDONE, ZIPRASIDONE, ZIPRASIDONE, |
||||
| 262 | 26557342 |
US |
65 | 2 |
Drug ineffective, |
||||
OLANZAPINE, OLANZAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, MIRTAZAPINE, MIRTAZAPINE, |
||||
| 263 | 26557343 |
US |
22 | 2 |
Drug ineffective, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, QUETIAPINE FUMARATE, QUETIAPINE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, CLONIDINE, MIRTAZAPINE, MIRTAZAPINE, MIRTAZAPINE, RISPERIDONE, RISPERIDONE, RISPERIDONE, SUVOREXANT, |
||||
| 264 | 26557376 |
69 | 2 | |
Drug ineffective, |
||||
TIRZEPATIDE, |
||||
| 265 | 26557378 |
US |
||
Drug ineffective, |
||||
TIRZEPATIDE, |
||||
| 266 | 26557383 |
US |
35 | 2 |
Haematochezia, Drug ineffective, Frequent bowel movements, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, ACYCLOVIR, BUDESONIDE, IRON, |
||||
| 267 | 26557407 |
US |
68 | 1 |
Epilepsy, Faeces hard, Gastrointestinal stoma output abnormal, Weight increased, Injection site bruising, Lethargy, Sensitivity to weather change, Drug ineffective, |
||||
TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, |
||||
| 268 | 26557452 |
US |
1 | |
Drug ineffective, |
||||
DUPILUMAB, |
||||
| 269 | 26557460 |
US |
1 | |
Drug ineffective, |
||||
DUPILUMAB, |
||||
| 270 | 26557496 |
US |
32 | 2 |
Hyponatraemia, Drug ineffective, |
||||
LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, PROCHLORPERAZINE, DEXTROSE MONOHYDRATE, DEXTROSE, WATER, ACONITUM NAP, ARSENICUM ALB, BORAX, CALC PHOS, GELSENIUM, LYCOPODIUM, PHOSPHORICUM AC, PICRICUM AC, PLUMB MET, SOLIDAGO, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, FAMOTIDINE, POLYETHYLENE GLYCOL, SENNOSIDES, SENNA LEAF, SENNA, |
||||
| 271 | 26557516 |
|||
Drug ineffective, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 272 | 26557540 |
US |
2 | |
Drug ineffective, |
||||
ELIGLUSTAT, |
||||
| 273 | 26557581 |
US |
1 | |
Drug ineffective, |
||||
DUPILUMAB, |
||||
| 274 | 26557643 |
EU |
83 | 1 |
Colitis microscopic, Impulse-control disorder, Drug ineffective, Somnolence, Sleep attacks, Oedema peripheral, |
||||
ROPINIROLE, BUDESONIDE, BUDESONIDE, OPICAPONE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MELATONIN, PANTOPRAZOLE, APIXABAN, CLONAZEPAM, |
||||
| 275 | 26557688 |
SG |
33 | 2 |
Cytomegalovirus colitis, Drug ineffective, Exposure during pregnancy, |
||||
MESALAMINE, INFLIXIMAB, |
||||
| 276 | 26557713 |
TR |
77 | 1 |
Drug ineffective, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, BORTEZOMIB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DARATUMUMAB, |
||||
| 277 | 26557757 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 278 | 26557761 |
US |
50 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 279 | 26557762 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 280 | 26557775 |
US |
43 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 281 | 26557776 |
US |
50 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 282 | 26557778 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 283 | 26557779 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 284 | 26557780 |
US |
30 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 285 | 26557783 |
US |
45 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 286 | 26557784 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 287 | 26557800 |
US |
59 | 1 |
Glycosylated haemoglobin increased, Drug ineffective, |
||||
DULAGLUTIDE, |
||||
| 288 | 26557817 |
EU |
14 | 1 |
Drug ineffective, |
||||
HUMAN IMMUNOGLOBULIN G, |
||||
| 289 | 26557820 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 290 | 26557821 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 291 | 26557823 |
US |
30 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 292 | 26557824 |
US |
30 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 293 | 26557829 |
1 | ||
Drug ineffective, |
||||
LORATADINE, LORATADINE TABLET, |
||||
| 294 | 26557847 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 295 | 26557848 |
US |
30 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 296 | 26557851 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 297 | 26557852 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 298 | 26557854 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 299 | 26557855 |
US |
40 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 300 | 26557856 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28